New Sabin Program Launched in 2008: Sustainable Immunization Financing

Immunization programs save hundreds of thousands of lives in the developing world, and the introduction of new vaccines will save millions more. As new, more expensive vaccines enter the global market, however, many developing countries are struggling to finance their immunization programs. To address this growing challenge, the Sabin Vaccine Institute has launched its latest initiative: the Advocacy Project for Sustainable Immunization Financing.

Vaccine Advocacy In the News

Similar to the Neglected Tropical Diseases (or NTDs) that plague developing nations, neglected infections of poverty exist in the United States and are impairing the physical, emotional and mental development of African American and Hispanic children nationwide. In the June 2008 edition of Public Library of Science’ Neglected Tropical Diseases journal, Dr.

Washington Post

New Sabin Program Launched in 2008: Sustainable Immunization Financing

Immunization programs save hundreds of thousands of lives in the developing world, and the introduction of new vaccines will save millions more. As new, more expensive vaccines enter the global market, however, many developing countries are struggling to finance their immunization programs. To address this growing challenge, the Sabin Vaccine Institute has launched its latest initiative: the Advocacy Project for Sustainable Immunization Financing.

Sabin

PLoS Article "Neglected Infections of Poverty in the United States of America" by Dr. Peter Hotez

In the United States, there is a largely hidden burden of diseases caused by a group of chronic and debilitating parasitic, bacterial, and congenital infections known as the neglected infections of poverty. Like their neglected tropical disease counterparts in developing countries, the neglected infections of poverty in the US disproportionately affect impoverished and under-represented minority populations.

PLoS

Health Experts Call on Global Leaders to Ensure Access to Life-Saving Pneumococcal Vaccines

Reykjavik, Iceland – Nearly 1,000 of the world’s leading experts on infectious diseases and vaccines are meeting during the 6th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-6) this week to call for renewed and urgent action by governments to protect their citizens against pneumococcal disease, a leading killer of children and adults worldwide.

Sabin

Pages